Dublin, May 02, 2025 (GLOBE NEWSWIRE) -- The "Fondaparinux Market Size, Share & Trends Analysis Report By Type (Deep Vein Thrombosis), By Product (Branded, Generic), By Distribution Channel (Hospital Pharmacies), By Region, And Segment Forecasts, 2025 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global fondaparinux market size is estimated to reach USD 990.9 million by 2030, registering to grow at a CAGR of 6.3% from 2025 to 2030 .
Fondaparinux is majorly used during knee and hip replacement surgeries. Arixtra, manufactured by GSK group of companies is the branded drug of Fondaparinux. The drug witnessed patent expiry in 2002. As the active molecule is highly complex to manufacture, it faced low generic competition until 2011. Generic manufacturer companies, such as Alchemia Ltd. and Apotex, Inc., received the Abbreviated New Drug Application approval in 2011 and instantly started the production of generic drugs.
Fondaparinux is used as an anticoagulant and shows improved survival compared with low-molecular-weight heparin. It is used for the prevention of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) and is administered subcutaneously. Moreover, Fondaparinux lowers the risk of ischemic events
The increasing collaboration between the key players for acquiring the Intellectual Property Rights (IPRs) in order to manufacture the molecule through patented technology is expected to drive growth.
Fondaparinux Market Report Highlights
- The generic segment accounted for the largest revenue share of 52.1% in 2024 and is expected to maintain its dominance during the forecast period.
- The Deep Vein Thrombosis (DVT) segment accounted for a leading share of the market in 2024.
- Hospital pharmacies emerged as the leading distribution channel for fondaparinux in 2024
- North America fondaparinux market dominated the global market and accounted for the largest revenue share of 37.6% in 2024
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This Report Addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 100 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value (USD) in 2024 | $688 Million |
| Forecasted Market Value (USD) by 2030 | $990.9 Million |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Fondaparinux Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter's Five Forces Analysis
3.3.2. PESTLE Analysis
Chapter 4. Fondaparinux Market: Type Business Analysis
4.1. Type Market Share, 2024 & 2030
4.2. Type Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Deep Vein Thrombosis
4.5. Pulmonary Embolism
Chapter 5. Fondaparinux Market: Product Business Analysis
5.1. Product Market Share, 2024 & 2030
5.2. Product Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.4. Branded
5.5. Generic
Chapter 6. Fondaparinux Market: Distribution Channel Business Analysis
6.1. Distribution Channel Market Share, 2024 & 2030
6.2. Distribution Channel Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
6.4. Hospital Pharmacies
6.5. Retail Pharmacies
6.6. Online Pharmacies
Chapter 7. Fondaparinux Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
Chapter 8. Competitive Landscape
- Abbott Laboratories Inc.
- Alchemia Limited
- Apotex Inc.
- GSK plc
- Lupin Pharmaceuticals, Inc
- ScinoPharm Taiwan Ltd
- Dr. Reddy's Laboratories Ltd.
- Bayer Healthcare
- GlaxoSmithKline
- Boehringer Ingelheim
- Sanofi
- WisMed
- Kaifeng
- Mylan
For more information about this report visit https://www.researchandmarkets.com/r/yo464t
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
